Early Hydroxychloroquine Use Reduced Deaths by 60 Percent, Says Prevent Senior

The protocol prevented one hospitalization for every 28 patients who started treatment and reduced hospitalizations, says the insurance carrier.

RIO DE JANEIRO, BRAZIL - A study conducted by Prevent Senior, a health care provider, assesses the use of Hydroxychloroquine at an early stage in patients suspected of having contracted the novel coronavirus.

According to the study, the use of the drug in the initial stage of the disease, when the patient presents only common flu symptoms, has a major impact in relieving hospitals in a pandemic scenario. The research awaits publication in the medical journal . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?